SOAGY OTC
Sartorius AG ADR
1W: -4.0%
1M: -0.3%
3M: +7.9%
YTD: -3.0%
1Y: +10.9%
3Y: -15.1%
5Y: -27.1%
$56.83
+0.57 (+1.02%)
Weekly Expected Move ±5.2%
$51
$54
$57
$60
$63
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$83.0B
52W Range46.97-62.15
Volume2,014
Avg Volume6,078
Beta1.52
Dividend$0.17
Analyst Ratings
Company Info
CEOMichael Grosse
Employees14,042
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2024-08-15
Websitesartorius.com
Otto-Brenner-Strasse 20
Göttingen, NI 37079
DE
Göttingen, NI 37079
DE
49 551 308 0
About Sartorius AG ADR
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
Recent Insider Trades
No insider trades found